• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌根治性治疗后对侧乳腺癌:发生率及相关临床病理和影像学危险因素。

Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors.

机构信息

Division of Breast Imaging, Department of Radiology, Massachusetts General Hospital, 55 Fruit Street (WAC 240), Boston, MA 02114, USA.

Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Clin Imaging. 2022 Feb;82:179-192. doi: 10.1016/j.clinimag.2021.11.018. Epub 2021 Nov 20.

DOI:10.1016/j.clinimag.2021.11.018
PMID:34872008
Abstract

PURPOSE

Patients who have ductal carcinoma in situ (DCIS) are undergoing bilateral mastectomy at increasing rates. One of the reasons is to minimize contralateral breast cancer (CBC) risk. The purpose of this study is to determine the rate of and risk factors associated with CBC in women treated for DCIS.

METHODS

A retrospective study was performed of women with DCIS at surgery from 2007 to 2014 who had at least five-year follow-up. Patient attributes, imaging findings, histopathology results, and surgical and long-term outcomes were collected. Features associated with a CBC were assessed with multivariable logistic regression models.

RESULTS

613 women (mean 56 years, range 30-87) with DCIS underwent breast-conserving surgery (BCS) (n = 426), unilateral mastectomy (n = 101), or bilateral mastectomy (n = 86), with mean follow-up of 7.9 years. Of the 527 women who had BCS or unilateral mastectomy, 7.4% (n = 39) developed a CBC (DCIS in 12 and invasive cancer in 27). 4.1% (5/122) of women treated with adjuvant endocrine therapy developed a CBC, compared to 8.4% (34/405) who were not treated (p = .11). Features associated with CBC risk were younger age at menarche (adjusted odds ratio [aOR] of 0.76, p = .03) and low nuclear grade of DCIS (aOR of 5.43 for grade 1 versus 3, p = .01).

CONCLUSION

In women treated for DCIS, the overall rate of CBC was low at 7.4%. Younger age at menarche and low nuclear grade of DCIS had significant associations with higher CBC risk.

摘要

目的

患有导管原位癌(DCIS)的患者正在以越来越高的比例接受双侧乳房切除术。原因之一是为了最大限度地降低对侧乳腺癌(CBC)的风险。本研究的目的是确定在接受 DCIS 治疗的女性中 CBC 的发生率和相关风险因素。

方法

对 2007 年至 2014 年接受手术治疗的 DCIS 女性患者进行回顾性研究,这些患者的随访时间至少为 5 年。收集患者特征、影像学表现、组织病理学结果以及手术和长期结果。使用多变量逻辑回归模型评估与 CBC 相关的特征。

结果

613 名(平均年龄 56 岁,范围 30-87 岁)患有 DCIS 的女性接受了保乳手术(BCS)(n=426)、单侧乳房切除术(n=101)或双侧乳房切除术(n=86),平均随访时间为 7.9 年。在接受 BCS 或单侧乳房切除术的 527 名女性中,7.4%(n=39)发生了 CBC(DCIS 12 例,浸润性癌 27 例)。接受辅助内分泌治疗的 122 名女性中有 4.1%(5/122)发生了 CBC,而未接受治疗的 405 名女性中有 8.4%(34/405)发生了 CBC(p=0.11)。与 CBC 风险相关的特征是初潮年龄较小(调整后的优势比 [aOR]为 0.76,p=0.03)和 DCIS 的核分级较低(核分级 1 与 3 相比,aOR 为 5.43,p=0.01)。

结论

在接受 DCIS 治疗的女性中,CBC 的总体发生率较低,为 7.4%。初潮年龄较小和 DCIS 的核分级较低与 CBC 风险显著相关。

相似文献

1
Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors.导管原位癌根治性治疗后对侧乳腺癌:发生率及相关临床病理和影像学危险因素。
Clin Imaging. 2022 Feb;82:179-192. doi: 10.1016/j.clinimag.2021.11.018. Epub 2021 Nov 20.
2
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.保乳手术与乳房切除术治疗导管原位癌患者的浸润性复发模式。
Breast Cancer Res Treat. 2021 Apr;186(3):617-624. doi: 10.1007/s10549-021-06129-3. Epub 2021 Mar 6.
3
Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?导管原位癌患者的对侧乳腺癌风险:是否高到足以支持双侧乳房切除术?
Ann Surg Oncol. 2017 Oct;24(10):2889-2897. doi: 10.1245/s10434-017-5931-2. Epub 2017 Aug 1.
4
Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.伴同侧小叶原位癌的导管原位癌患者对侧乳腺癌风险。
Ann Surg Oncol. 2019 Dec;26(13):4317-4325. doi: 10.1245/s10434-019-07796-9. Epub 2019 Sep 24.
5
Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era.现代单侧乳房切除术治疗导管原位癌患者的对侧乳腺癌风险和内分泌治疗应用。
Am J Surg. 2021 Mar;221(3):521-524. doi: 10.1016/j.amjsurg.2020.11.012. Epub 2020 Nov 9.
6
Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.降低导管原位癌的复发率:对30年间接受保乳手术的2996名女性的分析。
Ann Surg Oncol. 2015 Oct;22(10):3273-81. doi: 10.1245/s10434-015-4740-8. Epub 2015 Jul 28.
7
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
8
Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.导线引导下保乳手术后导管原位癌与浸润性乳腺癌的再次手术率
JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751.
9
Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.保乳治疗对导管原位癌女性的长期疗效。
Breast Cancer Res Treat. 2019 Dec;178(3):607-615. doi: 10.1007/s10549-019-05428-0. Epub 2019 Sep 6.
10
Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.年轻原位导管癌女性的局部治疗选择:一项比较保乳手术联合或不联合辅助放疗与乳房切除术的系统评价和荟萃分析
Breast. 2022 Jun;63:29-36. doi: 10.1016/j.breast.2022.03.006. Epub 2022 Mar 12.

引用本文的文献

1
Prediction of Surgical Upstaging Risk of Ductal Carcinoma In Situ Using Machine Learning Models.使用机器学习模型预测导管原位癌的手术分期升级风险
J Breast Imaging. 2023 Oct 17;5(6):695-702. doi: 10.1093/jbi/wbad071. eCollection 2023 Nov-Dec.
2
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.同侧肿瘤复发风险在患有导管原位癌的女性中:Van Nuys 预后指数和 Memorial Sloan Kettering 癌症中心列线图的应用。
Breast Cancer Res Treat. 2023 Nov;202(1):185-190. doi: 10.1007/s10549-023-07036-5. Epub 2023 Jul 30.
3
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
AGO早期乳腺癌患者诊断与治疗建议:2022年更新版
Breast Care (Basel). 2022 Aug;17(4):403-420. doi: 10.1159/000524879. Epub 2022 May 5.